Cycloserine, first isolated in 1954 as a fermentation product of Streptomyces orchidaceus (Harned et al., 1955) , has been extensively investigated in the treatment of tuberculosis. Toxicity in patients given large doses for prolonged periods is the major disadvantage of such therapy (Walker and Murdoch, 1957) . Nevertheless, lower oral dosage for short periods is virtually non-toxic provided renal function is good. Under these circumstances much higher urine than plasma concentrations are achieved (Welch et al., 1955) . Cycloserine has therefore been used.to a limited extent, with encouraging results, in patients suffering from infections of the urinary tract caused by a variety of organisms (Herrold et al., 1955; Hughes et al., 1958) . In vitro studies have also suggested-that concentrations of cycloserine sufficient to inhibit the growth of some strains of coliform organisms are attainable in human urine (Welch et al., 1955; Garrod, 1959) . We report here the results of a detailed study of the use of cycloserine in a small number of patients with severe infection of the urinary tract by coliform organisms who have been observed for periods of two to seven months.
Materials and Methods Clncai
Five female patients have so far been selected for study. Three were diabetic subjects who had suffered severe and repeated attacks of urinary infection characterized by malaise, frequency of micturition, nocturia, and dull loin pain for many months. Treatment with courses of sulphonamides, chloramphenicol, tetracyclines, and streptomycin had failed to relieve the symptoms or to render the urine sterile for an appreciable length of time. Renal biopsy was successfully performed in two of these three patients and histological evidence of pyelonephritis was demonstrated in both. Kidney tissue was not obtained from the third patient. The two remaining patients, who were not diabetic, had acute infections causing severe illness with high fever, rigors, dysuria, and oliguria of short duration. Renal biopsy was therefore not performed because of the delay involved in preparing for this procedure. Sinilarly, pre-treatment laboratory studies were also curtailed. Individual details of the patients are shown in Table I .
Treatment consisted of the daily oral administration of cycloserine in doses of 250 mg. eight-hourly for 14 days. Each patient was instructed not to drink excessively during this time. Daily observations of the temperature, pulse, and respiration rates and of the urinary volume were made. The patients were questioned and examined daily in respect of the subsidence or otherwise of their disease. Subjective and objective signs of drug toxicity, such as drowsiness, personality change, myoclonus, and epileptiform phenomena, were especially sought.
Bacteriological
As repeated catheterization carried with it the risk of introducing further infection, the following method of obtaining "clean" mid-stream specimens was devised. Patients were instructed to bathe in the early morning, washing the ano-genital region thoroughly with hexachlorophane soap. Urine was voided at 9 a.m. and discarded. Chlorhexidine cream was applied to the labia at 10.45 a.m. At 11 a.m. the patient, in the erect posture, with the labia separated by a sterile gloved hand, voided urine. The mid-urinary flow was collected in a wide-mouthed sterile jar and delivered immediately to the bacteriologist. Three such specimens were obtained on successive mornings before treatment was begun in Cases 1, 2, and 3. Only one such specimen was taken in Cases 4 and 5.
The pretreatment specimens from all patients were examined by standard laboratory procedures-namely, The antibiotic sensitivity pattern of these organisms was determined by the disk-diffusion method (Bowie and Gould, 1952) . The minimum concentration of cycloserine required to inhibit the growth of these strains of E. coli was determined in the following manner. A standard solution of cycloserine was prepared by dissolving 100 mg. of the drug in 100 ml. of meatextract broth. This was diluted appropriately, with broth, to give concentrations of cycloserine ranging from 1,000 to 25 ,ug. /ml. 0.5-ml. aliquots of these solutions were inoculated with 0.02 ml. of a 1 in 250 dilution of an overnight broth culture of the organisms under test. The concentrations of cycloserine required to produce growth iihibition were noted after 18 hours' incubation at 370 C. (see Table II ). (Jones, 1956) With one exception there was no evidence, either subjectively or objectively, of any toxicity attributable to cycloserine in the dosage employed. The patient (Case 3) who showed a mild personality change, characterized by phases of depression alternating with mild confusion, previously had impaired renal function (see Table III ) and in consequence had much higher plasma cycloserine levels than the other patients in the series. These toxic effects, however, rapidly disappeared at the end of treatment and were never severe enough to warrant withdrawal of the drug.
Figs. 1, 2, and 3 illustrate the bacteriological progress in Cases 1, 2, and 3 respectively, in relation to the urine and plasma concentrations of cycloserine achieved during treatment. They also illustrate that the urinary concentrations attained equal or exceed the minimum inhibitory concentrations of cycloserine required for the strains of E. coli isolated from these patients. Cases 4 and 5 achieved urine cycloserine concentrations of 113 and 172 jtg./ml. respectively, and these substantially exceeded the minimum inhibitory concentrations for their respective strains of E. coli. (see Table II ).
In every case microscopical evidence of pyuria disappeared when the urine became sterile. Followup studies at approximately monthly intervals have shown no bacteriological evidence of relapse (see Figs. 1-3 ).
There has been no marked change in the results of the renal-function tests during the period of the study, with the exception of Case 5. In this instance the marked increase in creatinine clearance probably reflects an improvement in fluid balance rather than a change in glomerular filtration efficiency.
Discussion
The treatment of recurrent infection of the urinary tract in women is notoriously difficult, and even after apparently successful treatment relapse is common. The incidence of such infections in female diabetic patients is much higher than in the general population (Barnard et al., 1953) and, like any infection in the diabetic subject, is apt to complicate the control of their disease. The three diabetic women included in this study were seriously ill on account of urinary infections which had proved resistant to multiple courses of sulphonamide and antibiotic treatment. In contrast, a single course of cycloserine, 250 mg. thrice daily for 14 days, gave a prompt and lasting remission of the infection, with consequent striking improvement both in their general health and in the state of their diabetes. The two young non-diabetic women had fulminating and very alarming illnesses due to coliform infection of the urinary tract, which was rapidly and completely controlled within 48 hours of starting treatment with cycloserine.
The strains of E. coli encountered in the present series have all shown similar sensitivities to cycloserine in vitro, though much more resistant strains have been reported by other workers (Hughes et al., 1958) 
